Cartoon representing researchers working on a combined therapy against metastatic melanoma, including safety, ethics and environmental aspects

Improving metastatic melanoma treatments

Metastatic melanoma is a hard-to-treat disease and it remains as one of the most worrisome cancer. There is an urgent need to improve the current therapies that have a limited efficacy.

Melomanes is a training-by-research project on an innovative immunotherapy treatment enhanced by nanoparticles.

Our research project

slant-separator

Melomanes aims to train a new generation of highly skilled doctoral researchers to emerge with a high-level training in the multidisciplinary field of nanomedicine.

Our goal? Develop a therapy for metastatic melanoma combining magnetic nanoparticles and CAR-T cells.

Our strategy? Use nanoparticles to induce damage on the tumor microenvironment, by magnetic and optic hyperthermia, in order to facilitate the infiltration of CAR-T cells.

Our approach? Integrate the safety, sustainability and ethics aspects within the research on the nanoparticles and immunotherapy.

Our impact beyond metastatic melanoma? Our therapeutic approach, combining hyperthermia and immunotherapy, is versatile. It could be applied to other types of solid tumors.

A cartoon representing researchers of different scientific fields: chemist, biologist, social scientist, data scientist

Our team

slant-separator

We are an interdisciplinary and international team of scientists

European Commission
European Commission
European Commission

Latest news

slant-separator

Discover our project

slant-separator

About

Learn more about our research project

Research Outputs

Find out about our research releases and outputs

News

Get the latest news about the project and the team

People

Discover a team of international and pluridisciplinary experts

Partner

Browse the list of the partners involved in the project

Events & Trainings

Find out about the events and training we propose